⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5553395 | 1.00 | — | — | |
| SCHEMBL9246448 | 1.00 | — | — | |
| SCHEMBL16208282 | 1.00 | — | — | |
| SCHEMBL6473918 | 0.82 | — | — | |
| SCHEMBL28801785 | 0.82 | — | — | |
| SCHEMBL6479837 | 0.82 | — | — | |
| SCHEMBL1325417 | 0.82 | — | — | |
| SCHEMBL23083 | 0.82 | — | — | |
| SCHEMBL23084 | 0.82 | — | — | |
| SCHEMBL1325430 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 109 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116589526-A | Modified rubber based on polypeptide, and preparation method and application thereof | 中国科学院长春应用化学研究所 | 2023-08-15 | — | — | CN | claimed |
| CN-103254069-A | Preparation method for trans, trans-2,4-hexadiene acetate | SHANDONG PESTICIDE RES INST | 2013-08-21 | — | — | CN | claimed |
| EP-0337333-B1 | PROCESS FOR TREATING USED AND SOILED ELECTRONICAL OR ELECTROMECHANICAL PARTS | Henkel Kommanditgesellschaft auf Aktien (DE) | 1993-08-18 | — | — | EP | claimed |
| CN-116655455-B | Method for synthesizing phyllitol | 天津大学 | 2025-04-04 | — | — | CN | disclosed |
| US-20240148699-A1 | OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2024-05-09 | — | — | US | disclosed |
| CN-116655455-A | Method for synthesizing phyllitol | 天津大学 | 2023-08-29 | — | — | CN | disclosed |
| CN-116589526-A | Modified rubber based on polypeptide, and preparation method and application thereof | 中国科学院长春应用化学研究所 | 2023-08-15 | — | — | CN | disclosed |
| US-20210113556-A1 | Piperazine-Substituted Benzothiophenes For Treatment of Mental Disorders | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2021-04-22 | — | — | US | disclosed |
| EP-3746436-A1 | FUSED RING COMPOUNDS | F. Hoffmann-La Roche AG (CH) | 2020-12-09 | — | — | EP | disclosed |
| CN-112048052-A | High oxygen permeation and high oxygen permeation hydrophilic polymer material | 亮点光学股份有限公司 | 2020-12-08 | — | — | CN | disclosed |
| US-20200237755-A1 | Piperazine-Substituted Benzothiophenes For Treatment of Mental Disorders | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2020-07-30 | — | — | US | disclosed |
| EP-1706368-A1 | PROCESS FOR PREPARING MONOESTERS | 3M Innovative Properties Company (US) | 2006-10-04 | — | — | EP | disclosed |
| EP-1678115-A2 | PROCESS FOR PREPARING FUNCTIONAL GROUP-CONTAINING OLEFINIC COMPOUNDS | 3M Innovative Properties Company (US) | 2006-07-12 | — | — | EP | disclosed |
| WO-2006068276-A1 | HAIR PROCESSING AGENT AND METHOD FOR PERMANENT WAVING HAIR | SHOWA DENKO K.K. (JP) | 2006-06-29 | — | — | WO | disclosed |
| WO-2006035954-A1 | CARBOSTYRIL COMPOUND | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2006-04-06 | — | — | WO | disclosed |
| EP-1328527-B1 | CEPHALOTAXANES, THEIR METHOD OF PREPARATION AND THEIR USE IN TREATMENT OF CANCERS, LEUKEMIAS, PARASITES INCLUDING THOSE RESISTANT TO USUAL CHEMOTHERAPEUTIC AGENTS AND AS REVERSAL AGENTS | STRAGEN PHARMA SA (CH) | 2006-03-08 | — | — | EP | disclosed |
| WO-2005066108-A1 | PROCESS FOR PREPARING MONOESTERS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2005-07-21 | — | — | WO | disclosed |
| WO-2005042462-A2 | PROCESS FOR PREPARING FUNCTIONAL GROUP-CONTAINING OLEFINIC COMPOUNDS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2005-05-12 | — | — | WO | disclosed |
| US-20040006064-A1 | Cephalotaxanes, their method of preparation and their use in treatment of cancers, leukemias, parasites including those resistant to usual chemotherapeutic agents and as reversal agents | IVAX International GmbH (CH) | 2004-01-08 | — | — | US | disclosed |
| US-6579869-B1 | Hydrolysis, esterification | ONCOPHARM CORPORATION | 2003-06-17 | — | — | US | disclosed |